Johnson & Johnson Loses Bid To Set Aside $4.7 Billion Award In Talc Asbestos Case
Thursday, 20 December 2018 Johnson & Johnson failed to persuade a Missouri trial judge to set aside a July verdict awarding a record $4.69 billion to 22 women who blamed their ovarian cancer on asbestos in the company’s Baby Powder and other talc products, Reuters reports. The healthcare company faces thousands of lawsuits over the safety of talc in its Baby Powder, a fixture of its consumer products division that has been core to J&J’s reputation as a family friendly company. The trial was the first in which plaintiffs claimed that asbestos fibers in J&J’s talc caused ovarian cancer. It relied on unsealed internal company documents detailing J&J’s alleged knowledge of asbestos contamination since at...
According to a report by Reuters, on Wednesday, Johnson and Johnson failed to persuade a Missouri trial judge to set aside a verdict awarding a record 4.69 billion dollars to 22 women who blamed their ovarian cancer on asbestos in the company's Baby Powder and other talc products. Court records show...
Johnson & Johnson said the Justice Department and U.S. Securities and Exchange Commission are investigating the company amid allegations Johnson's Baby Powder is contaminated with asbestos, a mineral..
On Wednesday, Johnson & Johnson it has received subpoenas from the U.S. Justice Department and the SEC. Reuters reports that it's related to litigation involving alleged asbestos contamination in its..
According to a report by Reuters, on Wednesday, a key supplier of talc used in Johnson & Johnson's baby powder filed for Chapter 11 bankruptcy in the wake of multibillion-dollar lawsuits alleging its..
Before the drama surrounding the Oscars asking Kevin Hart to be this host of to 2019 awards show, actor Dwayne "The Rock" Johnson claims he was the "first choice" for the gig by the Academy of Motion..
Credit: Wochit Entertainment Duration: 00:48Published
Johnson & Johnson has reported better than expected earnings for it's fourth quarter of 2018.
Business Insider reports that shares were sliding, down 1.39%.
The company's 2019 full-year guidance fell..
· Pharmaceutical giant Johnson and Johnson is buying surgical robotics company Auris Health for $3.4 billion.
· "In this new era of health care, we're aiming... Business Insider Also reported by •bizjournals •Reuters •WorldNews